Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients
NCT04728139 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2022-01-13
Summary
* Evaluation Of Glypican 3 in serum of colorectal cancer patients .
* Correlation between Glypican 3 and clinicopathological characteristics of colorectal cancer .
Conditions
Interventions
- DIAGNOSTIC_TEST
-
glypican 3
Assessment of glypican 3 presence in colorectal cancer patients using ELISA
Sponsors & Collaborators
-
Assiut University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-31
- Primary Completion
- 2024-09-30
- Completion
- 2024-10-31
More Related Trials
-
Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population
NCT01793207 ·Status: COMPLETED
-
Presence of Circulating Tumor DNA in Colorectal Cancer
NCT01198743 ·Status: COMPLETED
-
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
NCT01260168 ·Status: COMPLETED
-
A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence
NCT02005913 ·Status: UNKNOWN
-
Evaluation of Some Risk Factors Associated With Colorectal Cancer
NCT05170360 ·Status: UNKNOWN
-
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162 ·Status: COMPLETED
-
Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older
NCT04526314 ·Status: COMPLETED
-
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
NCT06889844 ·Status: RECRUITING
-
the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer
NCT05131243 ·Status: UNKNOWN ·Phase: NA
-
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883 ·Status: RECRUITING
-
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
NCT00625625 ·Status: UNKNOWN ·Phase: PHASE2
-
Predicting Disease Progression and/or Recurrence in Cancer
NCT04776837 ·Status: COMPLETED
-
Validation of Advanced Colorectal Neoplasm Risk Categories in a Prospective Cohort in Mexico
NCT05661292 ·Status: UNKNOWN
-
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
NCT03821948 ·Status: COMPLETED
-
Do Patients With Colorectal Cancer Understand That Their Family is at Risk?
NCT00145860 ·Status: TERMINATED
-
Gut Microbiome and Colorectal Cancer
NCT06748339 ·Status: COMPLETED
-
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT05785780 ·Status: RECRUITING ·Phase: NA
-
The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer
NCT01688232 ·Status: UNKNOWN
-
Impact of DietarY and LIfestyle Risk Factors on Colorectal Cancer Screening
NCT02804802 ·Status: UNKNOWN
-
Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance
NCT05528783 ·Status: RECRUITING
-
Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer
NCT07153458 ·Status: RECRUITING
-
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer
NCT00131599 ·Status: UNKNOWN
-
Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia
NCT05405673 ·Status: RECRUITING
-
Prevention and Early Detection Biomarkers of Adenomas and CRC Lesions During CRC Screening
NCT02596113 ·Status: COMPLETED
-
ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study
NCT05084833 ·Status: COMPLETED ·Phase: NA